Gabarol CR 165 Extended Releas Cr Tablet

Gabarol CR 165 Extended Releas Cr Tablet সম্পর্কে

বাংলাদেশে Gabarol CR 165 Extended Releas Cr Tablet Cr Tablet হিসেবে পাওয়া যায়; এতে Pregabalin আছে (১৬৫ mg)। Gabarol CR 165 Extended Releas-এর সাথে Pregabalin-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Advanced Chemical Industries PLC। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Pregabalin-এর ১০৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম GAPA-P 150 mg Capsule-এর, প্রতি ইউনিট ৳ ১।

Gabarol CR 165 Extended Releas Cr Tablet কী?

Gabarol CR 165 Extended Release is a tablet form of pregabalin, a medicine used in adults for nerve pain from diabetes or after shingles, and for fibromyalgia or spinal cord injury nerve pain. It is also used alongside other medicines for partial-onset seizures. The extended-release tablet is taken once daily, but the doctor sets the dose and how long it is taken. Common side effects include dizziness and sleepiness, so care is needed with driving or machinery until you know how it affects you. Do not stop it suddenly without medical advice.

Gabarol CR 165 Extended Releas-এর ব্যবহার

Gabarol CR 165 Extended Release is used for nerve pain linked to diabetes, shingles, or spinal cord injury, and for fibromyalgia. It can also be added to other treatment for partial-onset seizures. It is not a painkiller for everyday aches and is not for sudden pain. Only a doctor can decide if it suits your condition, and the dose and course are set by the doctor.

Gabarol CR 165 Extended Releas কীভাবে ব্যবহার করবেন

Swallow the extended-release tablet whole with water; do not crush or chew it. It is usually taken once daily, but follow the doctor's instructions exactly. The doctor decides the dose and how long you take it. Do not stop suddenly without advice, as this can cause problems. If you miss a dose, ask your pharmacist or doctor what to do rather than doubling up.

Gabarol CR 165 Extended Releas-এর পার্শ্বপ্রতিক্রিয়া

Common side effects include dizziness, sleepiness, dry mouth, swelling, blurred vision, weight gain, and trouble concentrating. These may affect driving or using machines, so avoid these until you know how the medicine affects you. Some people may have serious reactions such as swelling of the face or throat, trouble breathing, or mood changes. Seek medical help if you notice any of these, and tell your doctor about any side effect that bothers you.

সতর্কতা ও নিরাপত্তা

Do not use Gabarol CR 165 Extended Release if you are allergic to pregabalin or any ingredient. There are no adequate studies in pregnancy, so pregnant women should be told of possible risks to the baby; ask your doctor before use. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment because of a potential risk of tumour growth. Tell your doctor if you have kidney, breathing, or mental health problems, or if you take other medicines that make you sleepy. The doctor decides if it is suitable for you.

সাধারণ প্রশ্ন

Is Gabarol CR 165 Extended Release safe in pregnancy or breastfeeding?

There are no adequate studies in pregnant women, so the possible risks to the baby should be discussed with your doctor. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Ask your doctor before taking it if you are pregnant, planning pregnancy, or breastfeeding.

What is Gabarol CR 165 Extended Release used for and what kind of medicine is it?

It is a tablet containing pregabalin, used for certain nerve pain such as diabetic nerve pain, pain after shingles, fibromyalgia, and spinal cord injury nerve pain. It is also added to other medicines for partial-onset seizures. It is a prescription medicine, and the doctor decides if it is right for you.

How should Gabarol CR 165 Extended Release be stored?

Keep the tablets in a cool, dry place below 30°C, away from light and moisture. Keep the container out of the reach of children. Do not use it after the expiry date. Ask your pharmacist if you are unsure how to dispose of unused medicine.

Can I stop taking Gabarol CR 165 Extended Release suddenly?

No, do not stop suddenly without medical advice, as this can cause problems. The doctor will decide how to reduce or stop it safely. Always talk to your doctor or pharmacist before making any change to your treatment.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Pregabalin

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

GAPA-P Capsule

150 mg

Pregabalin

Renata PLC.

৳ ০.৯৮ ৳ ১ ২% ছাড় প্রতি ইউনিট

Asibalin Capsule

25 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ ৭.৮৪ ৳ ৮.০০ ২% ছাড় প্রতি ইউনিট

Venpa 25 mg Capsule

25 mg

Pregabalin

Maks Drugs Ltd.

৳ ৮.৮২ ৳ ৯ ২% ছাড় প্রতি ইউনিট

Pregaba 25 mg Capsule

25 mg

Pregabalin

Opsonin Pharma Limited

৳ ১০.২৯ ৳ ১০.৫ ২% ছাড় প্রতি ইউনিট

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ ১০.৭৮ ৳ ১১.০০ ২% ছাড় প্রতি ইউনিট

Prelica 25 mg Capsule

25 mg

Pregabalin

Radiant Pharmaceuticals Ltd.

৳ ১০.৭৮ ৳ ১১ ২% ছাড় প্রতি ইউনিট

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ ১১.৭৬ ৳ ১২.০০ ২% ছাড় প্রতি ইউনিট

Asibalin Capsule

50 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ ১১.৭৬ ৳ ১২.০০ ২% ছাড় প্রতি ইউনিট

Pretor 50 mg Capsule

50 mg

Pregabalin

Synovia Pharma PLC.

৳ ১১.৮ ৳ ১২.০৪ ২% ছাড় প্রতি ইউনিট

Broklin Capsule

50 mg

Pregabalin

One Pharma Ltd.

৳ ১২.৭৪ ৳ ১৩.০০ ২% ছাড় প্রতি ইউনিট

Preganaaf Capsule

50 mg

Pregabalin

Naafco Pharma PLC.

৳ ১৩.৭২ ৳ ১৪.০০ ২% ছাড় প্রতি ইউনিট

Neugalin Capsule

50 mg

Pregabalin

The ACME Laboratories Ltd.

৳ ১৪.৩১ ৳ ১৪.৬ ২% ছাড় প্রতি ইউনিট

সব দেখুন ১০৫ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।